The kinetic profiles of phenazepam and its hydroxylated derivative were compared in rat, dog, cat and man after administration of single oral doses of the parent compound. The absorption of phenazepam was reasonably rapid in all the species studied. Blood peak concentrations (Cmax) were reached at 1 h in rats (0.32 ± 0.03 μg/ml), at 0.5 h in dogs 0.54 ± 0.10 μg/ml), at about 2 h in cats (1.65 ±0.23 μg/ml), abut only at 4 h in man (0.038 μg/ml) at the highest dose tested. The largest normalized (value/dose) Cmax and area under the curve (AUC) were observed in man, while the rat gave the lowest values. The half-life of phenazepam was about 60 h in man, 13.72 ± 2.09 h in the cat, 6.35 ± 2.32 h in the dog and 7.49 ± 1.88 h in the rat (β-half-life). 3-OH-phenazepam was rapidly detected in cat, rat, and dog blood but no measurable amounts (<3 ng/ml) were found in human blood. At the oral doses tested, the ratio of the AUC for 3-OH-phenazepam to phenazepam was 0.01, 0.48, and 0.53 in the dog, rat, and cat, respectively. The half-life of the metabolite was shorter than that of the parent compound in the dog, but it was comparable in the rat and longer in the cat. The results suggest that 3-OH- phenazepam might contribute to the overall pharmacological effects of the parent compound in those species in which it accumulates in significant amounts.
|Number of pages||6|
|Journal||European Journal of Drug Metabolism and Pharmacokinetics|
|Publication status||Published - Jul 1982|
ASJC Scopus subject areas
- Pharmacology (medical)
- Pharmacology, Toxicology and Pharmaceutics(all)